Moderna plans 400% increase in price of Covid vaccine
Public Citizen Access to Medicines Director Peter Maybarduk and Northwestern healthcare economist Craig Garthwaite joins CNBC’s Brian Sullivan and ‘Last Call’ to discuss the debate over Moderna’s decision to raise the price of its Covid vaccine.
UP NEXT
NOW PLAYING: other
Moderna plans 400% increase in price of Covid vaccine
CNBC
UP NEXT
-
More companies in Southeast Asia will look to public markets to fund growth, Nomura says
CNBC
-
Recent polls say world energy system is no longer fit for purpose: World Energy Council
-
China's exports are likely to decelerate this month, economist says
-
It's possible the Fed will pause rate hikes this time around, professor says
-
'Crypto is not going away', says Digital Chamber's Perianne Boring on SEC lawsuit against Binance
-
At the end of the day 'this is a war', says fmr. Amb. McFaul on Ukraine-U.S. Nord Stream report
-
There will be a huge drop in spending once student loan payments resume, says Landry's CEO Fertitta
-
'Yasir Al-Rumayyan is going to be the most powerful person' in golf, says Barstool's Sam Bozoian
-
Lightning Round: If you have to buy Chinese stock buy Alibaba, says Jim Cramer
-
Timothy Massad: crypto risk 'isn't just about the token' it's about the 'platform you're trading on'
-
I wish someone would tell people messing in crypto it's possible to lose everything, says Jim Cramer
-
Most crypto assets named in SEC brief look like 'scams', says Jim Cramer
-
Magic Leap CEO: 'All boats are rising' in VR headset space after Apple introduces the Vision Pro
-
Call of the Day: SVB MoffettNathanson upgrades AT&T to Market Perform
-
Options Action: Puts outpacing calls for Coinbase
-
Merck's challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
